H.R. 6001: Veterans with ALS Reporting Act
This bill, titled the Veterans with ALS Reporting Act
, aims to enhance understanding and support for veterans affected by amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease. Here is a summary of the main components of the bill:
Report Requirements
The bill mandates that the Secretary of Veterans Affairs, collaborating with the Director of the Centers for Disease Control and Prevention (CDC), prepares and submits a comprehensive report to Congress within one year following its enactment. This report is expected to cover several key areas:
- Incidence and Prevalence: It will assess how many veterans are diagnosed with ALS and how widespread the disease is among this population.
- Resources and Support: It will describe the help and resources currently offered by the CDC and the Department of Veterans Affairs (VA) to assist veterans with ALS.
- Resource Deficiencies: The report will identify any gaps or shortcomings in the support systems for veterans diagnosed with ALS.
- Risk Reduction Strategies: It will propose strategies aimed at lowering the rates of ALS occurrence among veterans.
- Clinical Trials Participation: The bill will outline ways for veterans receiving ALS care in VA clinics to take part in relevant clinical trials and research conducted by the VA.
- Legislative Recommendations: Recommendations will be made for new laws that could help address challenges faced by veterans with ALS.
Tracking ALS Prevalence
The Secretary of Veterans Affairs is required to monitor how frequently ALS occurs among veterans. This tracking will utilize the existing registry and biorepository managed by the CDC that focuses on ALS cases.
Subsequent Reporting
In addition to the initial report, the Secretary of Veterans Affairs will need to provide updates to Congress at least every three years. These updates will include new findings on ALS prevalence among veterans, based on the ongoing tracking efforts.
Overall Purpose
The intent of this legislation is to ensure that there is a better understanding of ALS within the veteran community, to address the care needs of affected individuals, and to develop effective strategies to mitigate and manage the impact of this disease.
Relevant Companies
None found
This is an AI-generated summary of the bill text. There may be mistakes.
Sponsors
8 bill sponsors
Actions
4 actions
| Date | Action |
|---|---|
| Jan. 13, 2026 | Subcommittee Hearings Held |
| Nov. 17, 2025 | Referred to the Subcommittee on Health. |
| Nov. 10, 2025 | Introduced in House |
| Nov. 10, 2025 | Referred to the House Committee on Veterans' Affairs. |
Corporate Lobbying
0 companies lobbying
None found.
* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.
Potentially Relevant Congressional Stock Trades
No relevant congressional stock trades found.